To the Day Traders...THINK, as here are 4 near-term catalysts: - Announcement of EU distribution deals / upfront money - Results release of recent Vesele/Viagra study. Vesele sales will skyrocket - New Product launches (plus new distribution channels)...still at least 4 to come in 2017 - FlutiCare FDA approval of ANDA (Novalere). A 2nd manufacturer ! Tweet Tweet